Home Cart Sign in  
Chemical Structure| 5435-54-1 Chemical Structure| 5435-54-1
Chemical Structure| 5435-54-1
Product Citations

Alternative Products

Product Details of [ 5435-54-1 ]

CAS No. :5435-54-1
Formula : C5H4N2O3
M.W : 140.10
SMILES Code : OC1=C([N+]([O-])=O)C=NC=C1
MDL No. :MFCD00128874
InChI Key :YUWOLBZMQDGRFV-UHFFFAOYSA-N
Pubchem ID :228506

Safety of [ 5435-54-1 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Calculated chemistry of [ 5435-54-1 ] Show Less

Physicochemical Properties

Num. heavy atoms 10
Num. arom. heavy atoms 6
Fraction Csp3 0.0
Num. rotatable bonds 1
Num. H-bond acceptors 4.0
Num. H-bond donors 1.0
Molar Refractivity 35.08
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

78.94 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

0.87
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

0.88
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.7
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-1.34
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.21
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

-0.02

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-1.64
Solubility 3.2 mg/ml ; 0.0229 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Very soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.12
Solubility 1.06 mg/ml ; 0.00755 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-0.8
Solubility 22.0 mg/ml ; 0.157 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.53 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

2.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.85

Application In Synthesis [ 5435-54-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 5435-54-1 ]
  • Downstream synthetic route of [ 5435-54-1 ]

[ 5435-54-1 ] Synthesis Path-Upstream   1~1

  • 1
  • [ 5435-54-1 ]
  • [ 273-56-3 ]
References: [1] Journal of Heterocyclic Chemistry, 1990, vol. 27, # 3, p. 563 - 566.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 5435-54-1 ]

Ketones

Chemical Structure| 194278-44-9

A181445 [194278-44-9]

1-(3-Nitropyridin-2-yl)ethanone

Similarity: 0.56

Chemical Structure| 134612-80-9

A276434 [134612-80-9]

(4-Hydroxy-3-methoxy-5-nitrophenyl)(p-tolyl)methanone

Similarity: 0.54

Chemical Structure| 28177-69-7

A112781 [28177-69-7]

1-(2-Hydroxy-3-nitrophenyl)ethanone

Similarity: 0.52

Chemical Structure| 33852-43-6

A227830 [33852-43-6]

3'-Methoxy-2'-nitroacetophenone

Similarity: 0.52

Chemical Structure| 90923-05-0

A104411 [90923-05-0]

1-(3,6-Dimethoxy-2-nitrophenyl)ethanone

Similarity: 0.50

Nitroes

Chemical Structure| 31872-62-5

A115235 [31872-62-5]

4-Methoxy-3-nitropyridine

Similarity: 0.93

Chemical Structure| 1796-84-5

A341212 [1796-84-5]

4-Ethoxy-3-nitropyridine

Similarity: 0.90

Chemical Structure| 89282-12-2

A264497 [89282-12-2]

4-Hydroxy-3-nitropyridin-2(1H)-one

Similarity: 0.83

Chemical Structure| 629655-23-8

A219777 [629655-23-8]

2-Chloro-3-nitropyridin-4-ol

Similarity: 0.78

Chemical Structure| 6980-09-2

A309444 [6980-09-2]

2-Chloro-4-methoxy-3-nitropyridine

Similarity: 0.75

Related Parent Nucleus of
[ 5435-54-1 ]

Pyridines

Chemical Structure| 31872-62-5

A115235 [31872-62-5]

4-Methoxy-3-nitropyridine

Similarity: 0.93

Chemical Structure| 1796-84-5

A341212 [1796-84-5]

4-Ethoxy-3-nitropyridine

Similarity: 0.90

Chemical Structure| 89282-12-2

A264497 [89282-12-2]

4-Hydroxy-3-nitropyridin-2(1H)-one

Similarity: 0.83

Chemical Structure| 629655-23-8

A219777 [629655-23-8]

2-Chloro-3-nitropyridin-4-ol

Similarity: 0.78

Chemical Structure| 6980-09-2

A309444 [6980-09-2]

2-Chloro-4-methoxy-3-nitropyridine

Similarity: 0.75